Celldex Therapeutics
Clinical trials sponsored by Celldex Therapeutics, explained in plain language.
-
New shot aims to stop painful hives where standard meds fail
Disease control CompletedThis study tested an injectable drug called barzolvolimab (CDX-0159) for adults with chronic hives triggered by cold or skin friction. The goal was to see if it could better control symptoms in people whose hives weren't fully managed by standard antihistamine pills. Researchers …
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug targets root cause of painful swallowing disorder
Disease control CompletedThis study tested an investigational drug called barzolvolimab in adults with active eosinophilic esophagitis (EoE), a chronic inflammatory condition that makes swallowing difficult. The goal was to see if the drug could safely reduce the specific immune cells causing inflammatio…
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC